As the most common vascular emergency encountered by the vascular surgeons at Aurses Healthcare in Long Beach, who treat surrounding populations from Long Beach to San Pedro, Norwalk and beyond Los Angeles and Orange Counties, we know that as of 2025, critical limb ischemia (CLI) is a life-threatening condition and the endpoint manifestation of peripheral artery disease (PAD) that increases mortality as well as amputation risk. With increasing prevalence due to an aging population, increased diabetes (with over 11% of adults diagnosed in California currently) and socioeconomic challenges in our diverse population, it's no wonder that CLI prevalence rates have increased over time in our region. With over 2 million people experiencing this condition in the United States alone, and California representing a disproportionate share due to urban settings and increased access to healthcare, but also increased health disparities, we need to make CLI better known.

This is your extended guide to everything you need to know to feel comfortable about critical limb ischemia - what it is, how it happens, what we can prevent through awareness and desired outcomes through the PAAD continuum - its risk factors, complications (amputation mortality), treatment efficacy, what you need to know about local statistics, prevention tips and how Aurses Healthcare approaches treatment for our patients since especially with our experienced double board-certified surgeon team that performs all endovascular techniques and open surgical possibilities, we strive to save limbs before it's too late. CLI has a one-year mortality risk that mirrors many cancers, yet early intervention reduces amputation rates by over 70%. Let's begin with an outline of the basics so you can feel empowered for you and your family.

Critical Limb Ischemia is essentially a crucial condition of blood flow. It occurs when the arteries that feed an area of the body (most commonly the legs, the feet, and lower extremities) become so narrowed or occluded that there is not enough oxygen or nourishment to meet even the simplest catabolic needs of cellular function. In layman's terms, the body cells die by starvation, presenting with necrosis and gangrene and impending irreversible impairment unless some healing takes place. Essentially, limbs die when the vessels that are supposed to support them don't.

This occurs because the anatomical structure of the body is such that arteries emerge from the heart in a vascular tree with enough branching for all humans to receive adequate perfusion down to their lower areas. Thus, vessels continue to narrow until they reach their capillary ends, where exchange occurs. Ideally, at rest and even more with activity, perfusion meets metabolic demands. Critical limb ischemia takes such a hypothetical situation and transforms it into hell. Critical limb ischemia is the end stage of atherosclerosis, a pathological inflammatory process that forms plaque from cholesterol (low-density lipoprotein), calcium, and inflammatory cells, all within an artery.

Atherosclerosis does not happen overnight; critical limb ischemia is secondary to chronic processes. First, it starts with arterial disease, which begins with endothelial injury - an injured lining. Hypertension and smoking damage the endothelium (lining) of arteries as stress responses develop from subintimal insults. This endothelial injury triggers an inflammatory response, allowing monocytes (immune/inflammatory cells) to infiltrate the arterial wall and oxidize low-density lipoprotein cholesterol, forming fatty streaks. After decades, this fatty streak matures into a fibrous plaque that narrows the lumen to 50-70%. In CLI, obstruction occurs in 70-90% of cases, with perfusion pressure measured at the ankle less than 50 mmHg. This is the diagnostic criteria.

Second, there is microcirculatory failure - collateral vessels step in but fail - ischemia-reperfusion injury occurs. When a positional change accelerates blood flow into a previously obstructed vessel, an onslaught of oxygen-reactive species is unleashed, ready to cause further insult. Furthermore, neuropathy occurs primarily in a diabetic population in which diabetic critical limb ischemia is common; this means that symptoms that would typically be painful to the patient are occurring without perceptive ability, which allows for pathological progression without pain.

There is an epidemic of critical limb ischemia by 2025: In the medicare subpopulation, Incidence data show 220-350 per 100,000 per year, as cumulative prevalence is 0.23%. For patients aged >85 years, the prevalence of critical limb ischemia becomes 1.5%. In California, where peripheral artery disease has an adult prevalence between 8-12%, critical limb ischemia has represented 20-25% of all other vascular admissions per population study from California state health data reports. This substantiates "no option" classification limbs that are so compromised that even revascularization/reperfusion cannot help; in the cohort studies by 2025, one-year mortality is reported at 33%.

Critical limb ischemia is described by patients as a "thief in the night." It develops slowly and does not stop. Patients have rest pain at night; it is not alleviated by leg elevation. Ulcerative wounds do not heal and become necrotic black holes. However, it's not just a local effect in the extremities; it's a systemic marker for those with coronary and cerebral involvement, thus these patients are three times more likely to have heart attacks than their healthy counterparts without critical limb ischemia.

Unfortunately, limited information regarding CLI means that catching it early is critical, but its symptoms are not drastically different from those of neuropathy or arthritis. Classic triad: Excruciating (pain at rest), refractory pain (intra-digital/palm of foot/purplish 7-10 on pain scale), ischemic, gangrenous lesions of digits/forefoot, absent pulses in the foot. Note: Pain extends proximally up the calf and is worse at night due to dependency (further hindering perfusion efforts).

Compensatory mechanisms cause cool, ashy skin; hair reduction; atrophy of the skin (shiny and taut); and thickened nails, which are typical "critical" signs. Up to 50% of diabetic patients present "silently," according to the 2024 guidelines, with infections or foul-smelling death (necrosis). Other systemic signs include gradual weight changes and chronic tiredness secondary to anemia (chronic inflammatory states reduce erythropoiesis).

Aurses Healthcare begins diagnostic workup non-invasively; Ankle-brachial index scores <0.4 confirm severe PAD; toe pressure readings <30 confirm critical limb ischemia. In-house vascular lab offers duplex ultrasound for plaque mapping, with CT angiogram revealing multilevel disease; Given the patient's renal considerations, magnetic resonance angiogram (MRA) avoids iodinated contrast. The Wound, Ischemia, and foot Infection (WIfI) classification notes 2024 updates, wherein higher-risk levels indicate a 34.5% likelihood of amputation at one year.

The Long Beach clinic features point-of-care testing, including transcutaneous oxygen measurements (<30 mmHg signifies non-healable wounds). This means a team-of-teams approach involving surgical vascular specialists, wound care specialists, and endocrinologists promptly produces a 90% same-week consult review for newly diagnosed patients, per the 2025 recommendations from the American Heart Association.

CLI is not selected, but trends are revealed in our areas. Major impetus: Atherosclerosis; risk factors increase the likelihood by a factor of ten. At the top of the list is diabetes; 95% of CLI patients possess this comorbidity, confirmed in cohort studies from 2025. Glycosylating proteins from hyperglycemia 1) stiffen blood vessels and 2) promote thrombosis. In 2024, diabetes was reported in 12.5% of Los Angeles County residents; across the bridge, Orange County boasts a relatively lower 10.8%, with Latino (15%) and Black (13%) subpopulations as vulnerable subsets - food deserts run rampant in South LA and Santa Ana.

Smoking increases the risk of CLI by 2x and amputation after revascularization by 3x; California's smoking cessation statistics are present at 55%, according to 2025 CDC reports; San Pedro's port workers - 85% Latino - expose themselves to secondhand exposure up to 20% of the time. Hypertension is present in 48% of Los Angeles adults, increased endothelium degradation and hyperlipidemia promote plaque formation, and together, they confirm a four-fold increase in CLI incidence.

There is no escape from age; everyone is impacted after age 65 with an increase in risk - at age 85, incidence is 1% per year. Since the 2020 census, both counties' populations aged 65+ have increased by 18%, straining services. Chronic kidney disease is linked to 30% of CLI, predicting mortality at x2; clinics for dialysis in Norwalk report CLI rates at 40%. Obesity boasts a prevalence of 35% in Orange County (exacerbated by sedentary jobs, think: distribution centers). Obesity magnifies risk via inflammation; IL-6 is elevated in unstable plaque formation.

Socioeconomic disparities emerge via safety net hospitals - for example, one hospital serving East Los Angeles reports amputation rates after one year at 27%; in more affluent areas, they are around 15%. Family history, prior stroke/TIA history, or a hypercoagulable state (long haulers up by 15% after covid waves through Los Angeles by 2023) round out the profile. Women comprise 40% of CLI patients but are underdiagnosed because they present differently.

At Aurses Healthcare, we target these individuals for screening through community partnerships. We offer ABI screenings for free at Long Beach senior communities and wellness fairs in Norwalk; if you have more than two risk factors (or 1 factor if our risk calculator found you high-risk (accessible at our location), you should get tested.

CLI does not play kindly. CLI kills. One-year mortality is 20- 33% and five-year mortality is 60% - beyond most cancers - 48% of these deaths are attributed to cardiovascular events, as the shared atherosclerosis sees arteries in other areas (coronary) occluded, 20% die of associated renal failure. In the 2025 CLI trials of no-option patients, 33% were evaluated within one year; frailty and dementia have a 55% lifetime risk, with double the rate of no-option comparisons dying prematurely.

But even worse than death is amputation. Within one year, 25-45% of CLI patients undergo major (above-knee, below-knee) amputation; after six months of no intervention, 40% will need amputation. CLI presents in the diabetic population with major amputation rates of up to 21.7% in cohorts with recent revascularization histories. The revision rate of amputations is 15-20%. Five-year mortality post amputation is 40-70%. The cost to the healthcare system of one amputation is $50K+ per patient. Medi-Cal will incur significant expense for amputations across the state of CA.

Furthermore, these inequities exist across LA/Orange County, as Black patients have a 2x higher risk for amputation according to social determinants of health and delayed efforts. However, those who undergo revascularization as a more conservative approach undergo 50-70% fewer amputations overall.

Prevention is all about modifiable risks. Quit smoking via LA County's smoking cessation programs (you are 25% more likely to quit with others). Mediate your diabetes: an A1C of <7% means you are 50% less likely to get CLI; our weight loss clinic offers a weekly weight maintenance program in a supportive setting, with our patients losing an average of 15% of their body weight in 6 months. Work out for 150 minutes a week - walking helps develop collaterals. Statins and blood pressure/cholesterol monitoring according to the 2024 guidelines decrease progression by 30%. ABI is at risk in patients: PAD will develop into CLI if not diagnosed on time.

Aurses Healthcare is equipped for CLI, and 70% of CLI-required procedures are endovascular. Angioplasties (0.014 in., semi-compliant or drug-coated [paclitaxel - 80% patency at year 1]) and stenting (self-expanding nitinol, 40% decreased restenosis), femoral-popliteal or tibial-anterior/posterior revascularization (athrectomy) even removes plaque from arteries; best for calcified lesions. These are approached through the groin under local anesthesia with 1–2-day admissions thereafter.

Since 2025, these have had a 75% limb salvage rate at 1 year, with an 18% reduction in complications compared to an open approach. However, open approaches for more extensive disease include the fem-pop or tibial bypass with autologous vein (90% patency) or prosthetic grafts. Yet hybrid approaches combine both methods with good efficacy (85%). In addition, studies show that at 1-year follow-up, 70% of patients who underwent limb revascularization avoided amputation. For patients who received conservative treatment, the number was only 37%.

That's why we tailor to your needs: WIfI evaluation complemented by intra-op angiography from our cath lab boasts a 95% technical success rate.

Success requires maintenance: Dual antiplatelets for 6 months and statins for life. Should they return with a wound, we provide debridement/compression, and 80% of ulcers in our clinic heal this way. Rehab maintains ambulation; PT referrals restore 50% ambulation. Duplex every 3 months for monitoring.

In 2025, Aurses Healthcare collaborates with LA County Health for community screenings as CLI admissions rise 15% across the region. Pilot programs reduce amputations by 25%. We are your voice. We offer equitable care. We provide compassionate care.

Don't delay—CLI waits for no one. Schedule at www.aurseshealthcare.com/contact or call. Walk into a healthier future.

For a comprehensive list of relations with all health care institutions, Insurance and facilities please visit our affiliates section of our website.